HCA Healthcare, Inc. $HCA Stock Position Raised by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.0% in the second quarter, Holdings Channel.com reports. The institutional investor owned 218,180 shares of the company’s stock after purchasing an additional 6,386 shares during the quarter. Envestnet Asset Management Inc.’s holdings in HCA Healthcare were worth $83,585,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of HCA. Brighton Jones LLC bought a new position in HCA Healthcare in the 4th quarter worth about $1,021,000. Alta Advisers Ltd bought a new position in HCA Healthcare in the 1st quarter worth about $313,000. Mather Group LLC. grew its position in HCA Healthcare by 19.5% in the 1st quarter. Mather Group LLC. now owns 1,360 shares of the company’s stock worth $470,000 after purchasing an additional 222 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its position in HCA Healthcare by 0.9% in the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 24,496 shares of the company’s stock worth $8,465,000 after purchasing an additional 229 shares during the last quarter. Finally, DAVENPORT & Co LLC increased its stake in shares of HCA Healthcare by 5.8% during the first quarter. DAVENPORT & Co LLC now owns 11,985 shares of the company’s stock valued at $4,141,000 after acquiring an additional 652 shares during the period. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on HCA. Morgan Stanley set a $425.00 price objective on shares of HCA Healthcare in a research note on Monday. The Goldman Sachs Group raised their price objective on shares of HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a research note on Monday. Sanford C. Bernstein reiterated a “market perform” rating and set a $417.00 price objective on shares of HCA Healthcare in a research note on Monday. Oppenheimer raised their target price on shares of HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a report on Monday. Finally, Jefferies Financial Group raised their target price on shares of HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a report on Tuesday. Fourteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $473.53.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $468.21 on Thursday. The company has a 50 day moving average price of $418.76 and a 200 day moving average price of $385.09. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $475.38. The firm has a market capitalization of $109.56 billion, a price-to-earnings ratio of 18.10, a P/E/G ratio of 1.37 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same quarter last year, the business posted $4.90 EPS. The company’s revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.